Discovery Life Sciences™ acquires East West Biopharma

Discovery Life Sciences™ announced the acquisition of East West Biopharma, a leading human biospecimen contract research organization in Europe powered by the largest biocollection network in Ukraine. 

The addition of East West Biopharma builds on Discovery's existing capability and creates Europe's largest network of clinical collection sites that ethically obtain consented biospecimens from patients across multiple therapeutic areas to support the global medical research community.

Glenn Bilawsky, CEO of Discovery Life Sciences Commented "This acquisition represents the culmination of a highly productive and mutually successful partnership between our companies, East West Biopharma has a long-standing reputation for its commitment to quality, compliance, and operating to the highest regulatory and ethical standards for procuring biospecimens.  It perfectly complements our previous acquisition of Sofia Bio and its extensive network of human biospecimen collection sites in Bulgaria, Romania, and Poland. These two acquisitions combined with our US-based business now position Discovery as both the largest biospecimen service provider in Europe and globally."

Tetyana Yurkovska, General Manager of East West Biopharma Commented "For more than 15 years, we have provided biospecimens and human tissue related solutions to leading biomedical research organizations, including European and US academic institutes, the pharmaceutical industry, large biobanks, and biorepositories, Becoming a part of Discovery gives us the opportunity to open Ukraine to the global scientific community by providing access to our vast site network, thus fully supporting the Discovery Life Sciences mission of delivering science at researchers' service worldwide."

Related Posts

Subscribe Our Newsletter